An official website of the United States government
TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2012
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Alabama | 268 | 56.8 | 6.1 | (44.8 – 68.8) | 271 | 57.1 | 6.1 | (45.1 – 69.1) |
| Arizona | 222 | 59.2 | 7.4 | (44.7 – 73.7) | 229 | 44.4 | 10.3 | (24.2 – 64.6) |
| California | 316 | 59.4 | 4.4 | (50.8 – 68.0) | 336 | 57.6 | 4.4 | (49.0 – 66.2) |
| Connecticut | 241 | 58.0 | 5.2 | (47.8 – 68.2) | 249 | 55.6 | 5.7 | (44.4 – 66.8) |
| District of Columbia | 98 | 34.9 | 9.4 | (16.5 – 53.3) | 106 | 29.4 | 8.0 | (13.7 – 45.1) |
| Florida | 215 | 49.9 | 8.0 | (34.2 – 65.6) | 230 | 51.6 | 7.6 | (36.7 – 66.5) |
| Georgia | 142 | 46.8 | 7.6 | (31.9 – 61.7) | 160 | 45.9 | 7.0 | (32.2 – 59.6) |
| Hawaii | 143 | 40.2 | 7.8 | (24.9 – 55.5) | 152 | 54.6 | 6.4 | (42.1 – 67.1) |
| Illinois | 205 | 51.4 | 6.6 | (38.5 – 64.3) | 219 | 45.2 | 6.7 | (32.1 – 58.3) |
| Indiana | 238 | 46.7 | 5.9 | (35.1 – 58.3) | 260 | 41.3 | 5.5 | (30.5 – 52.1) |
| Iowa | 197 | 50.1 | 6.7 | (37.0 – 63.2) | 201 | 51.2 | 6.6 | (38.3 – 64.1) |
| Kansas | 388 | 50.6 | 4.8 | (41.2 – 60.0) | 402 | 50.4 | 4.7 | (41.2 – 59.6) |
| Louisiana | 261 | 56.0 | 6.8 | (42.7 – 69.3) | 274 | 48.9 | 6.9 | (35.4 – 62.4) |
| Maine | 216 | 56.1 | 5.7 | (44.9 – 67.3) | 228 | 57.2 | 5.2 | (47.0 – 67.4) |
| Massachusetts | 198 | 49.0 | 6.3 | (36.7 – 61.3) | 232 | 46.1 | 5.7 | (34.9 – 57.3) |
| Michigan | 448 | 60.8 | 4.0 | (53.0 – 68.6) | 488 | 60.2 | 3.9 | (52.6 – 67.8) |
| Mississippi | 261 | 62.5 | 5.6 | (51.5 – 73.5) | 261 | 64.0 | 5.5 | (53.2 – 74.8) |
| Missouri | 227 | 69.9 | 6.7 | (56.8 – 83.0) | 240 | 63.0 | 7.0 | (49.3 – 76.7) |
| Montana | 277 | 59.7 | 5.7 | (48.5 – 70.9) | 289 | 57.0 | 5.8 | (45.6 – 68.4) |
| Nebraska | 508 | 53.7 | 4.4 | (45.1 – 62.3) | 523 | 52.6 | 4.4 | (44.0 – 61.2) |
| Nevada | 142 | 52.8 | 8.4 | (36.3 – 69.3) | 158 | 49.0 | 8.0 | (33.3 – 64.7) |
| New Hampshire | 264 | 43.8 | 5.0 | (34.0 – 53.6) | 281 | 44.3 | 4.7 | (35.1 – 53.5) |
| New Jersey | 385 | 55.4 | 4.9 | (45.8 – 65.0) | 409 | 53.1 | 4.9 | (43.5 – 62.7) |
| New Mexico | 292 | 60.5 | 4.9 | (50.9 – 70.1) | 307 | 58.5 | 4.6 | (49.5 – 67.5) |
| New York | 173 | 51.0 | 7.0 | (37.3 – 64.7) | 189 | 45.8 | 7.7 | (30.7 – 60.9) |
| North Carolina | 155 | 64.9 | 7.3 | (50.6 – 79.2) | 174 | 60.8 | 7.5 | (46.1 – 75.5) |
| North Dakota | 150 | 53.3 | 7.2 | (39.2 – 67.4) | 149 | 50.1 | 7.4 | (35.6 – 64.6) |
| Ohio | 393 | 57.0 | 4.8 | (47.6 – 66.4) | 416 | 56.8 | 5.2 | (46.6 – 67.0) |
| Oklahoma | 210 | 47.0 | 6.5 | (34.3 – 59.7) | 216 | 42.5 | 6.6 | (29.6 – 55.4) |
| Oregon | 198 | 66.8 | 5.6 | (55.8 – 77.8) | 220 | 61.9 | 5.5 | (51.1 – 72.7) |
| Pennsylvania | 577 | 57.6 | 5.0 | (47.8 – 67.4) | 617 | 55.1 | 4.9 | (45.5 – 64.7) |
| Rhode Island | 187 | 61.8 | 6.0 | (50.0 – 73.6) | 190 | 57.0 | 6.7 | (43.9 – 70.1) |
| Texas | 212 | 59.8 | 8.2 | (43.7 – 75.9) | 220 | 52.8 | 9.3 | (34.6 – 71.0) |
| Vermont | 234 | 58.4 | 5.4 | (47.8 – 69.0) | 244 | 54.9 | 5.4 | (44.3 – 65.5) |
| Washington | 463 | 59.8 | 4.3 | (51.4 – 68.2) | 487 | 58.8 | 4.0 | (51.0 – 66.6) |
| West Virginia | 211 | 44.3 | 4.5 | (35.5 – 53.1) | 212 | 45.8 | 4.5 | (37.0 – 54.6) |
| Wisconsin | 181 | 55.6 | 8.2 | (39.5 – 71.7) | 185 | 56.6 | 8.2 | (40.5 – 72.7) |
| 37 state total | 9,496 | 55.9 | 1.5 | (53.0 – 58.8) | 10,024 | 53.0 | 1.5 | (50.1 – 55.9) |
| Median | 56.0 | 53.1 | ||||||
| Range | 34.9-69.9 | 29.4-64.0 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline sample size excludes “DK/Refused”
§ Standard error
† Confidence interval